Serum estrogen levels and prostate cancer risk in the prostate cancer prevention trial: a nested case–control study

OBJECTIVE: Finasteride reduces prostate cancer risk by blocking the conversion of testosterone to dihydrotestosterone. However, whether finasteride affects estrogens levels or change in estrogens affects prostate cancer risk is unknown. METHODS: These questions were investigated in a case–control st...

Celý popis

Uloženo v:
Podrobná bibliografie
Hlavní autoři: Yao, Song, Till, Cathee, Kristal, Alan R., Goodman, Phyllis J., Hsing, Ann W., Tangen, Catherine M., Platz, Elizabeth A., Stanczyk, Frank Z., Reichardt, Juergen K. V., Tang, Li, Neuhouser, Marian L., Santella, Regina M., Figg, William D., Price, Douglas K., Parnes, Howard L., Lippman, Scott M., Thompson, Ian M., Ambrosone, Christine B., Hoque, Ashraful
Médium: Artigo
Jazyk:Inglês
Vydáno: Springer Netherlands 2011
Témata:
Original Paper
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC3139891/
https://ncbi.nlm.nih.gov/pubmed/21667068
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s10552-011-9787-7
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky